Abstract:CONSPECTUS: Plants in the Schisandraceae family are important components of the traditional Chinese herbal medicines and are often used to treat various illnesses. Therefore, these Schisandraceae plants are valuable sources for the discovery of new chemical entities for novel therapeutic development. Considerable progress has been made in the identification of bioactive and structurally novel triterpenoids from the Schisandraceae family in the past two decades. In particular, Sun and co-workers have successfully isolated over 100 nortriterpenoids from the Schisandraceae family. Some of these nortriterpenoids have strong inhibitory activities toward hepatitis, tumors, and HIV-1. However, the natural scarcity of these nortriterpenoids in the Schisandraceae plants has hampered their isolation and further biomedical development, and their biosynthesis has not been fully elucidated. It is therefore important and urgent to develop efficient and streamlined total syntheses of these medicinally important nortriterpenoids. Such syntheses will provide sufficient materials for detailed biological studies as well as new synthetic analogues and probe molecules to improve their biological functions and elucidate their mode of actions. However, because of their structural novelty and complexity, the total syntheses of these nortriterpenoid natural products present a significant challenge for synthetic chemists, despite the progress made in organic synthesis, particularly total synthesis, in the 20th century and since the beginning of the 21st century. New synthetic methodologies and strategies therefore need to be invented and developed to facilitate the total syntheses of these nortriterpenoid natural products. With this in mind, our group has spent the last 15 years, ever since the isolation of micrandilactone A (1) by Sun and co-workers in 2003 (Sun et al. Org. Lett. 2003, 5, 1023-1026), working on synthetic studies with a view to developing methods and strategies for the total syntheses of schinortriterpenoids. Enabling methods such as a thiourea/Pd-catalyzed alkocycarbonylative annulation and a thiourea/Co-catalyzed Pauson-Khand reaction have been developed under these circumstances to form the key ring systems and stereocenters of these complex target molecules. These methodological advances have led us to the first total syntheses of schindilactone A (2), lancifodilactone G acetate (6a), 19-dehydroxyarisandilactone A (9), and propindilactone G (10) with diverse structural features via a branching oriented strategy. The chemistry developed during our total synthesis campaign has not only helped us to deal with various challenges encountered in the syntheses of the four target molecules, but has also opened up new avenues for synthesizing other naturally occurring schinortriterpenoids and their derivatives, which will likely result in molecules with improved biological functions and tool compounds to enable elucidation of their mechanism of actions or potential cellular targets. This Account highlights the chemistry evolution of our schinortriterpenoid syntheses.

Schinortriterpenoids with Identical Configuration but Distinct ECD Spectra Generated by Nondegenerate Exciton Coupling

Nortriterpenoids from Schisandra Chinensis and Their Absolute Configurational Assignments by Electronic Circular Dichroism Study

Two New 18-Norschiartane-type Schinortriterpenoids from Schisandra lancifolia.

Schicagenins A-C: Three Cagelike Nortriterpenoids from Leaves and Stems of Schisandra Chinensis.

Schilancitrilactones A–C: Three Unique Nortriterpenoids from Schisandra Lancifolia

LC–UV-Guided Isolation and Structure Determination of Lancolide E: A Nortriterpenoid with a Tetracyclo[5.4.0.02,4.03,7]undecane-Bridged System from a “Talented” Schisandra Plant

Lancolides, antiplatelet aggregation nortriterpenoids with tricyclo[6.3.0.02,11]undecane-bridged system from Schisandra lancifolia

Structure Characterization and Possible Biogenesis of Three New Families of Nortriterpenoids: Schisanartane, Schiartane, and 18‐Norschiartane

ChemInform Abstract: Structural Characterization and Antioxidative Activity of Lancifonins: Unique Nortriterpenoids from Schisandra Lancifolia.

Schipropins A–J, structurally diverse triterpenoids from Schisandra propinqua

Neuroprotective schinortriterpenoids with diverse scaffolds from Schisandra henryi

Synthesis of hept-6-en-2,4,5-triols and hept-6-en-2,3,5-triols

Four New Lignans from the Leaves and Stems of Schisandra Propinqua Var. Sinensis

Rearranged 19- Nor-7,8- Seco-Labdane Diterpenoids and Diels-Alder Cycloadducts from the Chinese Liverwort Pallavicinia Ambigua: Structural Elucidation, Photoinduced Rearrangement, and Cytotoxic Activity

Schisphenlignans A-E: Five New Dibenzocyclooctadiene Lignans From Schisandra Sphenanthera

Triterpenoids from the Schisandraceae Family: an Update

Five new nortriterpenoids from the stems of Schisandra neglecta

The Journey of Schinortriterpenoid Total Syntheses

Unusual immunosuppressive pyridine-containing, bisnor- (c23), tetranor- (c21) and pentanor- (c20) sesterterpenoids from Tibetan Leucosceptrum canum

Penicimeroterpenoids A–C, Meroterpenoids with Rearrangement Skeletons from the Marine-Derived Fungus Penicillium sp. SCSIO 41512

(+)/(−)-Alexanoid A, a Pair of Enantiomeric Sesquiterpenoid with a Novel 5/6/6 Tricyclic Backbone from the Stem of Syringa Pinnatifolia